Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROVIDENCE: Sexual Health and QoL in Cervical Cancer Patients
NCT07412873Phase 4Not yet recruiting
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Mar 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Cervical Cancer (CC) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Improvement in sexual function and self-perceived quality of life using Patient-Reported Outcomes at 12 months. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07412873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07412873.